ArticleFrontiers in medicine2025

Efficacy and safety of dolutegravir plus lamivudine for patients with late presentation of HIV-1 infection: a retrospective real-world cohort study in Southwest China.

Qing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.